Furthermore, by relating the CCLE data to the reported BC cell line subtype analysis (Lehmann et al., 2011), we found higher EHD2 mRNA expression to be a feature of TNBC cell lines, especially the mesenchymal-type (Figure 2D), similar to our western blot results (Figure 2A) where both EHD2-expressing TNBC cell lines were of the mesenchymal-type Figure 2D. This evidence concerns the gene EHD2 and breast cancer.